Skip to content

Multicenter randomized double-blind controlled clinical research about the effects of Repetitive transcranial magnetic stimulation in first-episode schizophrenia

Multicenter randomized double-blind controlled clinical research about the effects of Repetitive transcranial magnetic stimulation in first-episode schizophrenia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16009593
Enrollment
Unknown
Registered
2016-10-25
Start date
2016-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia

Interventions

Drug therapy control group:Drug
Drug + rTMS therapy research group:Drug + rTMS

Sponsors

Shanghai Tongji Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: First-episode schizophrenia group (200 cases) meet following items: 1. Comply with the diagnostic criteria of schizophrenia or schizophreniform psychosis according to DSM-5; 2. Aged 18-30 years old, the Han people, right-handed, to be able to recept rTMS treatment; 3. The first episode, less than 2 years course; 4. More than 70 intelligence quotient according to wechsler intelligence scale; 5. The family and the patients' informed consent.

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1. rTMS or MRI contraindications; 2. Mental retardation, diseases of nervous system or major body diseases; 3. History of brain injury, MRI showed abnormal brain structure; 4. History of alcohol or drug abuse and dependence; 5. Accepted MECT, long-term use of anticholinergic or benzodiazepines drugs may affect cognitive function.

Design outcomes

Primary

MeasureTime frame
fMRI;Clinical symptoms;Cognitive function;

Countries

China

Contacts

Public ContactLu Zheng

Shanghai Tongji Hospital

luzheng@tongji.edu.cn+86 13671902719

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026